U S PHYSICAL THERAPY INC /NV - Common Stock (USPH)

Historical Holders from Q1 2014 to Q3 2025

Symbol
USPH on NYSE
CUSIP
90337L108
Type / Class
Equity / Common Stock
Shares outstanding
15.2M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
16M
Holdings value
$1.36B
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
240
Number of buys
122
Number of sells
-111
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of U S PHYSICAL THERAPY INC /NV - Common Stock (USPH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14.2% $167M 2.16M BlackRock, Inc. Jun 30, 2025
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 9.8% +60.7% $126M $46.6M 1.49M +58.9% Kayne Anderson Rudnick Investment Management, LLC Jun 30, 2025
MORGAN STANLEY 5.9% $62.8M 890K Morgan Stanley Dec 31, 2024
Copeland Capital Management, LLC 5.54% -5.17% $71.7M $14.2M 844K +24.7% Copeland Capital Management, LLC Sep 30, 2025

Institutional Holders of U S PHYSICAL THERAPY INC /NV - Common Stock (USPH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 16M $1.36B +$38.8M $84.95 240
2025 Q2 15.6M $1.22B +$28.8M $78.20 239
2025 Q1 15.3M $1.11B -$19.8M $72.36 252
2024 Q4 15.6M $1.38B +$13.8M $88.71 254
2024 Q3 15.4M $1.3B +$16.7M $84.63 253
2024 Q2 15.2M $1.4B -$59.1M $92.42 240
2024 Q1 15.6M $1.76B +$15.3M $112.87 234
2023 Q4 20.6K $1.92M -$113K $93.14 2
2023 Q3 15.4M $1.41B +$3.26M $91.73 216
2023 Q2 15.2M $1.85B +$186M $121.39 209
2023 Q1 13.5M $1.32B +$29M $97.91 192
2022 Q4 13.4M $1.09B +$72.8M $81.03 193
2022 Q3 13.1M $996M -$73.4M $76.02 185
2022 Q2 13M $1.42B +$34.8M $109.20 203
2022 Q1 12.7M $1.26B +$9.42M $99.45 202
2021 Q4 12.6M $1.2B -$13.5M $95.55 201
2021 Q3 12.7M $1.4B -$4.94M $110.60 205
2021 Q2 12.6M $1.46B +$11.5M $115.87 213
2021 Q1 12.4M $1.29B -$18.3M $104.10 203
2020 Q4 12.8M $1.53B -$23.3M $120.25 196
2020 Q3 13M $1.13B -$46.8M $86.88 174
2020 Q2 11.3M $915M +$15.5M $81.02 176
2020 Q1 11.1M $767M +$15.7M $69.00 187
2019 Q4 12.8M $1.47B -$43.6M $114.35 204
2019 Q3 13.2M $1.72B +$758K $130.55 213
2019 Q2 13.2M $1.61B +$13.1M $122.57 206
2019 Q1 13.1M $1.38B +$18.5M $105.03 211
2018 Q4 13M $1.33B +$34M $102.35 188
2018 Q3 12.6M $1.5B +$23.1M $118.60 188
2018 Q2 12.4M $1.19B +$29M $96.00 176
2018 Q1 12.2M $991M +$21.9M $81.30 167
2017 Q4 11.9M $860M +$8.98M $72.20 159
2017 Q3 11.9M $729M -$8.51M $61.45 164
2017 Q2 11.8M $713M -$1.74M $60.40 168
2017 Q1 11.9M $774M +$123M $65.30 174
2016 Q4 12.1M $847M +$31.8M $70.20 168
2016 Q3 11.7M $734M -$2.12M $62.70 170
2016 Q2 11.7M $703M -$1.03M $60.21 163
2016 Q1 11.6M $575M -$29.7M $49.73 146
2015 Q4 12.3M $659M +$31.2M $53.68 139
2015 Q3 11.5M $519M +$6.09M $44.89 129
2015 Q2 10.4M $567M +$16.4M $54.76 127
2015 Q1 11.3M $537M +$6.34M $47.50 126
2014 Q4 11.2M $472M +$2.84M $41.96 124
2014 Q3 11.2M $397M +$5.22M $35.39 111
2014 Q2 11M $377M -$698K $34.19 104
2014 Q1 11.1M $382M +$4.07M $34.57 105